'Too much of a good thing': can network meta-analysis guide treatment decision-making in psoriatic arthritis?

Rheumatology (Oxford). 2021 Jul 1;60(7):3042-3044. doi: 10.1093/rheumatology/keab329.

Authors

Helena Marzo-Ortega^{1

2}, Jon Packham^{3

4}, Mar Pujades-Rodriguez^{5

6}

Affiliations

¹ NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds.
³ Haywood Rheumatology Centre, Stoke on Trent.
⁴ Division of Public Health and Epidemiology, University of Nottingham.
⁵ Real World Solution, IQVIA, London.
⁶ Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

PMID: 33792657
DOI: 10.1093/rheumatology/keab329

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Arthritis, Psoriatic* / drug therapy
Humans
Network Meta-Analysis